Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97870982 | 9787098 | 2 | F | 20091217 | 20151204 | 20131228 | 20160831 | EXP | GB-ROCHE-1325820 | ROCHE | 44.00 | YR | M | Y | 0.00000 | 20160831 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97870982 | 9787098 | 1 | PS | CAPECITABINE. | CAPECITABINE | 1 | Oral | TWICE DAILY ON DAYS 1-21 | U | 20896 | |||||||||
| 97870982 | 9787098 | 2 | SS | GEMCITABINE HYDROCHLORIDE. | GEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | OVER 30 MINUTES ON DAYS 1, 8 AND 15 (REPORTED AS PER PROTOCOL)) | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 97870982 | 9787098 | 1 | Pancreatic carcinoma |
| 97870982 | 9787098 | 2 | Pancreatic carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 97870982 | 9787098 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 97870982 | 9787098 | Abdominal pain lower | |
| 97870982 | 9787098 | Device occlusion | |
| 97870982 | 9787098 | Diarrhoea | |
| 97870982 | 9787098 | Nausea | |
| 97870982 | 9787098 | Pancreatitis | |
| 97870982 | 9787098 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |